UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000060074
Receipt number R000056521
Scientific Title Efficacy of contrast-enhanced harmonic EUS for gallbladder tumor
Date of disclosure of the study information 2025/12/13
Last modified on 2025/12/12 18:16:14

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Efficacy of contrast-enhanced harmonic EUS for gallbladder tumor

Acronym

Efficacy of contrast-enhanced harmonic EUS for gallbladder tumor

Scientific Title

Efficacy of contrast-enhanced harmonic EUS for gallbladder tumor

Scientific Title:Acronym

Efficacy of contrast-enhanced harmonic EUS for gallbladder tumor

Region

Japan


Condition

Condition

gallbladder tumor

Classification by specialty

Hepato-biliary-pancreatic medicine

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the diagnostic capability in terms of differentiating malignant from benign for gallbladder tumor with contrast-enhanced EUS

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Whether contrast-enhanced harmonic EUS improves the accuracy of differentiating benign from malignant gallbladder tumors compared to B-mode EUS

Key secondary outcomes

The optimal evaluation method for gallbladder tumors in differentiating malignant from benign with contrast-enhanced harmonic EUS


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

100 years-old >=

Gender

Male and Female

Key inclusion criteria

*Long axis of lymph node <10 mm
*Pathological diagnosis obtained by surgery or EUS-FNA

Key exclusion criteria

*Cases with obvious distant metastasis or local invasion
*Blood coagulation disorder or a platelet
count of less than 50,000/uL
*Taking anticoagulant or antiplatelet drugs
*Pregnancy
*Egg allergy
*Failure of other organs

Target sample size

62


Research contact person

Name of lead principal investigator

1st name Kensaku
Middle name
Last name Yoshida

Organization

Gifu Prefectural General Medical Center

Division name

Gastroenterology

Zip code

500-8717

Address

4-6-1 Noishiki, Gifu-City

TEL

0582461111

Email

kensakuyoshidaky@gmail.com


Public contact

Name of contact person

1st name Yoshida
Middle name
Last name Kensaku

Organization

Gifu Prefectural General Medical Center

Division name

Gastroenterology

Zip code

500-8717

Address

4-6-1 Noishiki, Gifu-City

TEL

0582461111

Homepage URL


Email

kensakuyoshidaky@gmail.com


Sponsor or person

Institute

Department of Gastroenterology, Gifu Prefectural General Medical Center

Institute

Department

Personal name



Funding Source

Organization

Department of Gastroenterology, Gifu Prefectural General Medical Center

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Gifu University Hospital

Address

1-1, yanagido, Gifu, Gifu

Tel

0582306000

Email

takuji@w7.dion.ne.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 12 Month 13 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

86

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2021 Year 03 Month 31 Day

Date of IRB

2022 Year 04 Month 20 Day

Anticipated trial start date

2021 Year 04 Month 01 Day

Last follow-up date

2024 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

A total of 86 patients were enrolled, and the analysis has been completed.


Management information

Registered date

2025 Year 12 Month 12 Day

Last modified on

2025 Year 12 Month 12 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000056521